Paul Little
Operating Partner
Operating Partner at 麻豆社 BioCapital.
Paul Little joined the early stage biotech investment unit 麻豆社 Emerge in 2016 as an associate. Paul鈥檚 focus is on scientific evaluation and commercial assessment of early investment opportunities. He is CEO of Vesper Biotechnology and Board Representative in Folium.
CEO of Vesper Biotechnology
Board Representative: Folium Science
